💨 Abstract

Sun Pharmaceutical, India's largest drugmaker, reported a 15% increase in Q3 profit, driven by strong domestic sales growth. Sales in India rose 14% to 43 billion rupees, with the global specialty pharmaceutical segment seeing a 17.5% jump in sales. Overall revenue increased 10.5% to 136.75 billion rupees, despite a 0.7%

Courtesy: theprint.in

Summarized by Einstein Beta 🤖